Retatrutide benn peptide la bu am 39 asid amino yuñ defaree ci backbone GIP ngir stimuler GLP-1, GIP, ak GCGRs
Benn agoniste reseptër bu am glucagon la (GLP-1, GIP, ak GCGR reseptër). Ci biir gëstu bi, ñi ci bokk ñu jël dose bi gëna rëy (12 mg) dañu wane ni 24,2% ci wàññi diisaay bi ginaaw 48 ayu-bis.
Retatrutide mooy agoniste bu am ñatti yoon, di wut reseptëri glucagon, polypeptide inhibitëru gastrik, ak glucagon- bu niro ak peptide {6}1. Mekanismu retamtrutide bi ci jëf mooy jëflante ak reseptër yooyu, loolu mooy tax insulin bi di gëna yokk, gëna yokk homeostase glucose, ak modulaasioŋu appetite bu baax. Doxalin klinik yi ci fase 1 ba 3 dañu wane njariñ yu am solo, ñu wane ni wàññeeku bu baax ci diisaayu yaram ak njariñu glycémie bu baax. Rax ci dolli, retamtrutide dafay wane dige ci wàññi facteur risk kardiyovaskulaar ak saafara jafe-jafe metabolik- feebar steatatic steatacié. Waaye, dañu wara bàyyi xel bu baax ngir mëna wax ci profilu kaaraange bu yàgg, banneexu ci limu mëna am ci askan wu amul fenn, dindi bépp liggéey bu jëm ci paj mi, ba noppi leeral anam yi mu mëna defee ci cohorts pediatrik yi. Ci anam wu ñuy soppi paj mi, retamtrutide dafay màndargaal yaakaaru yaakaar, di wane coppite yi am ci paysage bi ñuy jëfandikoo ci wàllu yaram ak diabet type 2 (T2DM), ba noppi di jàppale ci gëstu ak setal ci jëf klinik. Revue nettali bii dafay jàngat njariñu paj mi ci wàllu faj yaram wu ëpp ak T2DM.
produit
rapoor jàngat
feedback kiliyaan
Duggal
Packagage ak dem ak dikk
Sunuy jaar yoon
Kalite bu rëy, njëg bu am taxawaayu njëkk, ak njëg yu doy ak njëg yu gaaw ci joxe.
99% ci seeni standard.
Nun defarkat lañu, te mën nanu am produit yu baax ak njëgu usin bi.
Gaawaayu kaaraange ak gaaw
1) Mën nañu yónnee Parcel ci 3 fani liggéey ginaaw biñu fayyee. nimero toppu.
2) Séggal ak yu nekk ci loxo. anam yu bari ngir dem ak dikk.
3) Njàngat yi dañuy romb 99%
FAQ
Hot Tags: 10mg 15mg 15mg 10mg 10 violu, retamtrutide bu Chine 5mg 10mg 10mg 15mg 30mg 30mg 10 defarkatu violu.